New Dual-Use Biothreat Research Review Policy

March 31, 2012

Federal officials released a new policy this week requiring agencies to systematically review the potential risks associated with federally funded studies involving pathogens and toxins considered high consequence risk, including the H5N1 [Read more]

Mishaps Revealed at Army Biodefense Lab

March 14, 2012

According to documents obtained by The Frederick News-Post under the Freedom of Information Act, more than 200 mishaps were reported at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) at [Read more]

White Powder Letters Sent to U.S. Senate

February 23, 2012

Several more U.S. Senate district offices have received letters containing a suspicious powder, though the powder has been found to be harmless, according to reports from CBS News. The news comes after the Senate [Read more]

NIAID Funds $9.4M for Next-Gen Anthrax Vaccine

January 3, 2012

Biopharmaceutical company Soligenix, through an agreement with Harvard University, will be working towards a next-generation single-dose anthrax vaccine under a $9.4 million National Institute of Allergy and Infectious Disease (NIAID) grant. Soligenix received [Read more]

1 14 15 16